Torrent Pharma Enters Semaglutide Market with New Launch

Key Highlights • Launched oral & injectable Semaglutide formulations in India • Brands: Sembolic and Semalix • Priced at around ₹3,999 per month Why It Matters With multiple players entering the GLP-1 segment, competition is intensifying. Pricing and product differentiation (oral vs injectable) will play a key role in market share capture. Learning Outcome In high-growth therapy segments, increased competition post-patent expiry leads to price discovery and wider adoption. Investors should track pricing, accessibility, and product positioning.